{"id":"https://openalex.org/W3004453240","doi":"https://doi.org/10.1200/jco.2020.38.5_suppl.tps86","title":"NANORAY-1100: A phase I study of NBTXR3 activated by radiotherapy in patients with advanced cancers treated with anti-PD-1 therapy.","display_name":"NANORAY-1100: A phase I study of NBTXR3 activated by radiotherapy in patients with advanced cancers treated with anti-PD-1 therapy.","publication_year":2020,"publication_date":"2020-02-04","ids":{"openalex":"https://openalex.org/W3004453240","doi":"https://doi.org/10.1200/jco.2020.38.5_suppl.tps86","mag":"3004453240"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.5_suppl.tps86","doi":"https://doi.org/10.1200/jco.2020.38.5_suppl.tps86","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.5_suppl.tps86","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040202861","display_name":"Colette J. Shen","orcid":"https://orcid.org/0000-0002-3855-7360","observed_orcids":["https://orcid.org/0000-0002-3855-7360"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colette J. Shen","raw_affiliation_strings":["University of North Carolina at Chapel Hill, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill, Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075204448","display_name":"Katherine LaRoque Jameson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine LaRoque Jameson","raw_affiliation_strings":["Vanderbilt Univ Medcl Ctr, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt Univ Medcl Ctr, Nashville, TN;","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022384270","display_name":"Jared M. Weiss","orcid":"https://orcid.org/0000-0003-2961-4447","observed_orcids":["https://orcid.org/0000-0003-2961-4447"]},"institutions":[{"id":"https://openalex.org/I4210123841","display_name":"University of North Carolina Hospitals","ror":"https://ror.org/0355zfr67","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1333535994","https://openalex.org/I4210123841"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jared Weiss","raw_affiliation_strings":["University of North Carolina Hospitals, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina Hospitals, Chapel Hill, NC;","institution_ids":["https://openalex.org/I4210123841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079585578","display_name":"Trevor Hackman","orcid":"https://orcid.org/0000-0001-9330-2398","observed_orcids":["https://orcid.org/0000-0001-9330-2398"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Trevor Hackman","raw_affiliation_strings":["Department of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robert Dixon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Dixon","raw_affiliation_strings":["University of North Carolina At Chapel Hill, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina At Chapel Hill, Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078927238","display_name":"Jason Akulian","orcid":"https://orcid.org/0000-0002-4528-8496","observed_orcids":["https://orcid.org/0000-0002-4528-8496"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason A. Akulian","raw_affiliation_strings":["University of North Carolina, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina, Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031626209","display_name":"Alexander T. Pearson","orcid":"https://orcid.org/0000-0003-2801-7456","observed_orcids":["https://orcid.org/0000-0003-2801-7456"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander T. Pearson","raw_affiliation_strings":["University of Chicago, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Ann Arbor, MI;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023129507","display_name":"Jessica M. Frakes","orcid":"https://orcid.org/0000-0002-1901-0933","observed_orcids":["https://orcid.org/0000-0002-1901-0933"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Frakes","raw_affiliation_strings":["Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Patricia Said","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801713495","display_name":"Nanobiotix (France)","ror":"https://ror.org/047ts9g27","country_code":"FR","type":"company","lineage":["https://openalex.org/I2801713495"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Patricia Said","raw_affiliation_strings":["Nanobiotix, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nanobiotix, Paris, France;","institution_ids":["https://openalex.org/I2801713495"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008467612","display_name":"Tanguy Y. Seiwert","orcid":"https://orcid.org/0000-0001-7919-8272","observed_orcids":["https://orcid.org/0000-0001-7919-8272"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tanguy Y. Seiwert","raw_affiliation_strings":["The University of Chicago Medicine, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago Medicine, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"5_suppl","first_page":"TPS86","last_page":"TPS86"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11176","display_name":"Radiation Therapy and Dosimetry","score":0.01860000006854534,"subfield":{"id":"https://openalex.org/subfields/3108","display_name":"Radiation"},"field":{"id":"https://openalex.org/fields/31","display_name":"Physics and Astronomy"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.5569999814033508},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9049999713897705},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.8299999833106995},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":0.949999988079071},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":1.0},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.6010000109672546},{"id":"https://openalex.org/keywords/abscopal-effect","display_name":"abscopal effect","score":0.8069999814033508},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.5960000157356262},{"id":"https://openalex.org/keywords/immune-markers","display_name":"immunological markers","score":0.5120000243186951},{"id":"https://openalex.org/keywords/nanomedicine","display_name":"nanomedicine","score":0.5},{"id":"https://openalex.org/keywords/reirradiation","display_name":"re-irradiation","score":0.7020000219345093},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.6809999942779541},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.6439999938011169},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.42800000309944153}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9176687002182007},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6619043350219727},{"id":"https://openalex.org/C2781274730","wikidata":"https://www.wikidata.org/wiki/Q4669679","display_name":"Abscopal effect","level":4,"score":0.6581531763076782},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.6036902070045471},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5502000451087952},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5385798811912537},{"id":"https://openalex.org/C2776530083","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck cancer","level":3,"score":0.5078743100166321},{"id":"https://openalex.org/C2780283643","wikidata":"https://www.wikidata.org/wiki/Q2110267","display_name":"Primary tumor","level":4,"score":0.4730733335018158},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4692409336566925},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4609115719795227},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4606151580810547},{"id":"https://openalex.org/C2776833033","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck squamous-cell carcinoma","level":4,"score":0.4331860840320587},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3532702326774597},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.32368987798690796},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2880646586418152}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.5_suppl.tps86","doi":"https://doi.org/10.1200/jco.2020.38.5_suppl.tps86","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.5_suppl.tps86","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2995541646","https://openalex.org/W3028755997","https://openalex.org/W3172797708","https://openalex.org/W3098930643","https://openalex.org/W3208325803","https://openalex.org/W3093899263","https://openalex.org/W4308385787","https://openalex.org/W4308397844","https://openalex.org/W4386784019","https://openalex.org/W4379281897"],"abstract_inverted_index":{"TPS86":[0],"Background:":[1],"Most":[2],"cancer":[3,215,226],"patients":[4,14],"present":[5],"resistance":[6],"to":[7,16,23,43,61,80,142,155,166,178,203,262,269],"immune":[8,17,306],"therapy;":[9],"only":[10],"approximately":[11],"15%":[12],"of":[13,29,47,101,159,183,205,232,238,249,277,282,295],"respond":[15],"checkpoint":[18],"inhibitors":[19],"(ICI).":[20],"Strategies":[21],"able":[22],"increase":[24,44,81,115,156],"ICI":[25,48,160,164],"response":[26,118,272,274],"are":[27,56,268],"thus":[28],"great":[30],"interest.":[31],"Radiotherapy":[32],"(RT),":[33],"by":[34,58,71,112,131,255,301],"acting":[35],"as":[36],"an":[37],"immunomodulator":[38],"is":[39,91,171,244,261],"a":[40,65,151,172,247],"good":[41],"candidate":[42],"the":[45,78,87,116,144,157,206],"proportion":[46,158],"responders.":[49,167],"However,":[50],"RT":[51,82,113,146],"dose":[52,84],"and":[53,105,122,181,193,196,280,285,304],"ultimate":[54],"efficacy":[55],"limited":[57],"potential":[59],"toxicity":[60],"healthy":[62,102],"tissues.":[63,103],"NBTXR3,":[64],"first":[66],"in":[67,133,185],"class":[68],"radioenhancer":[69],"administered":[70],"intratumoral":[72],"injection,":[73,284],"has":[74],"been":[75],"designed":[76],"at":[77],"nanoscale":[79],"energy":[83],"deposition":[85],"within":[86],"tumor.":[88],"The":[89,258],"result":[90],"increased":[92],"radiation-dependent":[93],"tumor":[94,251],"cell":[95,199],"killing,":[96],"without":[97],"increasing":[98],"radiation":[99],"exposure":[100],"Preclinical":[104],"early":[106],"clinical":[107],"data":[108],"suggest":[109],"NBTXR3":[110,129,241,283,286],"activated":[111,130],"can":[114],"anti-tumor":[117,271],"yielding":[119],"both":[120],"local":[121,145],"systemic":[123,152],"(abscopal)":[124],"effects.":[125],"We":[126],"hypothesize":[127],"that":[128],"RT,":[132],"combination":[134],"with":[135],"anti-PD-1":[136,239],"therapy":[137],"(R3/RT/PD-1),":[138],"will":[139,235,292],"act":[140],"synergistically":[141],"maximize":[143],"effect":[147,153],"while":[148],"also":[149],"producing":[150],"sufficient":[154],"responders":[161],"or":[162,191,219],"convert":[163],"non-responders":[165],"Methods:":[168],"NANORAY-1100":[169],"[NCT03589339]":[170],"multicenter,":[173],"open-label,":[174],"phase":[175],"1":[176],"study":[177],"evaluate":[179,270],"safety":[180,279],"tolerability":[182],"R3/RT/PD-1":[184,264,296],"three":[186],"cohorts:":[187],"(1)":[188],"Locoregionally":[189],"recurrent":[190,192],"metastatic":[194],"head":[195],"neck":[197],"squamous":[198],"carcinoma":[200],"(HNSCC)":[201],"amenable":[202],"re-irradiation":[204],"HN":[207],"field,":[208],"(2)":[209],"Lung":[210],"metastases":[211,222],"from":[212,223],"any":[213,224],"primary":[214,225,259],"eligible":[216,227],"for":[217,228],"anti-PD-1,":[218],"(3)":[220],"Liver":[221],"anti-PD-1.":[229],"Approximately":[230],"two-thirds":[231],"each":[233],"cohort":[234],"be":[236],"composed":[237],"non-responders.":[240],"injection":[242],"volume":[243,252],"based":[245],"on":[246],"percentage":[248],"gross":[250],"(GTV)":[253],"determined":[254],"central":[256],"review.":[257],"objective":[260],"determine":[263],"RP2D.":[265],"Secondary":[266],"objectives":[267,291],"(objective":[273],"rate;":[275],"ORR)":[276],"R3/RT/PD-1,":[278],"feasibility":[281],"body":[287],"kinetic":[288],"profile.":[289],"Exploratory":[290],"assess":[293],"biomarkers":[294],"response,":[297],"including":[298],"PD-L1":[299],"status":[300],"IHC,":[302],"mRNA":[303],"cytokine":[305],"marker":[307],"profiling.":[308],"Clinical":[309],"trial":[310],"information:":[311],"NCT03589339.":[312]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-03T13:16:28.481748","created_date":"2020-02-14T00:00:00"}